Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Poluzzi

Showing results (51-60 of 189) with videos related to

Pageof 19
Sort By:
Recenti Progressi in Medicina|December 16, 2015
[The key role of patient in the antipsychotic therapy: shared decision making, adherence and research]Francesca Gallingani, Carlo Piccinni, Angela Simeoni, et al.
British Journal of Clinical Pharmacology|December 17, 2008
Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year periodEmanuel Raschi, Elisabetta Poluzzi, Chiara Zuliani, et al.
European Journal of Clinical Pharmacology|November 12, 2003
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursementElisabetta Poluzzi, Domenico Motola, Chiara Silvani, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 1, 2017
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug developmentAnna Girardi, Emanuel Raschi, Silvia Galletti, et al.
Journal of Nephrology|November 11, 2021
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systemsMilo Gatti, Michele Fusaroli, Emanuel Raschi, et al.
Expert Opinion on Drug Safety|July 19, 2021
Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting systemMilo Gatti, Michele Fusaroli, Emanuel Raschi, et al.
International Journal of Cardiology|September 22, 2018
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting SystemRiccardo Mei, Emanuel Raschi, Emanuele Forcesi, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic AppraisalEmanuel Raschi, Michele Fusaroli, Milo Gatti, et al.
British Journal of Clinical Pharmacology|July 9, 2020
Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19Milo Gatti, Michele Fusaroli, Paolo Caraceni, et al.
Journal of Affective Disorders|April 12, 2026
Apixaban, direct oral anticoagulants and psychiatric events: Innocent bystander or true safety signal?Emanuel Raschi, Charles Khouri, Chiara Gastaldon, et al.
Pageof 19

Showing results (51-60 of 189) with videos related to

Sort By:
Pageof 19
Recenti Progressi in Medicina|December 16, 2015
[The key role of patient in the antipsychotic therapy: shared decision making, adherence and research]Francesca Gallingani, Carlo Piccinni, Angela Simeoni, et al.
British Journal of Clinical Pharmacology|December 17, 2008
Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8-year periodEmanuel Raschi, Elisabetta Poluzzi, Chiara Zuliani, et al.
European Journal of Clinical Pharmacology|November 12, 2003
Prescriptions of antidepressants in primary care in Italy: pattern of use after admission of selective serotonin reuptake inhibitors for reimbursementElisabetta Poluzzi, Domenico Motola, Chiara Silvani, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 1, 2017
Drug-induced renal injury in neonates: challenges in clinical practice and perspectives in drug developmentAnna Girardi, Emanuel Raschi, Silvia Galletti, et al.
Journal of Nephrology|November 11, 2021
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systemsMilo Gatti, Michele Fusaroli, Emanuel Raschi, et al.
Expert Opinion on Drug Safety|July 19, 2021
Serious adverse events with tedizolid and linezolid: pharmacovigilance insights through the FDA adverse event reporting systemMilo Gatti, Michele Fusaroli, Emanuel Raschi, et al.
International Journal of Cardiology|September 22, 2018
Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting SystemRiccardo Mei, Emanuel Raschi, Emanuele Forcesi, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Liver Injury with Nintedanib: A Pharmacovigilance-Pharmacokinetic AppraisalEmanuel Raschi, Michele Fusaroli, Milo Gatti, et al.
British Journal of Clinical Pharmacology|July 9, 2020
Serious adverse events with tocilizumab: Pharmacovigilance as an aid to prioritize monitoring in COVID-19Milo Gatti, Michele Fusaroli, Paolo Caraceni, et al.
Journal of Affective Disorders|April 12, 2026
Apixaban, direct oral anticoagulants and psychiatric events: Innocent bystander or true safety signal?Emanuel Raschi, Charles Khouri, Chiara Gastaldon, et al.
Pageof 19